Special NoticePosted Jul 30, 2026·Responses due Aug 14, 2026

Notice of intent to sole source Genetic Analyzer system

Defense Health Agency · DEFENSE HEALTH AGENCY

Stage
Early notice (sources sought, presolicitation or special notice)
NAICS
334516
Value
Not stated
Solicitation
HT942726R0730
Set-aside
No Set aside used
PSC
Not stated
Place
USA
Contact
Roberto Gonzalez (roberto.a.gonzalez-echeverria.civ@health.mil)
CSV Email

Capture briefs (a one-page, shareable copy of this page) are part of Pro. The CSV here holds the notice, its timeline and past awards.

Where this opportunity stands

Every notice posted under solicitation HT942726R0730 in this department, oldest first.

Early notice
  • Jul 30, 2026 · this notice
    Special Notice
Solicitation
None posted
Award
Not yet. Typical award: Aug 19, 2026 to Oct 6, 2026, middle of the range Aug 30, 2026.
Measured from 67 past early notices at Defense Health Agency (Dha) that later posted an award (middle half of cases, counted from Jul 30, 2026).

Next steps for this stage

Standard steps for the notice type; not advice about this buyer.

  • Answer the notice: this is when the requirement can still be shaped.
  • Contact the contracting officer named on the notice.
  • Check who won similar work; they are the likely bidders.

What the notice says

THIS IS A NOTICE OF INTENT TO AWARD A SOLE-SOURCE CONTRACT AND IS NOT A REQUEST FOR COMPETITIVE PROPOSALS. The Defense Health Agency Contracting Activity (DHACA) in coordination with the Armed Forces Medical Examiner System DNA Operations requests a Firm Fixed Price (FFP) contract with Life Technologies Corporation. AFMES requires the purchase, delivery, installation, and extended warranty of one (1) Life Technologies Applied Biosystems SeqStudio 24 Flex Genetic Analyzer system. This system includes the main instrument, associated software, installation, and training. The acquisition includes … (show all)

the main instrument, all associated software and accessories, delivery, installation, training, and extended warranty services. Technical Specifications The delivered system must meet the following minimum essential characteristics: System Type: A 24-capillary electrophoresis system with 8-dye capable chemistry for advanced multiplexing. Laser: A solid-state, long-life 505 nm laser providing signal uniformity. Thermal System: An advanced thermal system to ensure precise temperature control for demanding DNA fragment analysis. User Interface: An integrated touchscreen computer with on-board data collection software for instrument control, run setup, and real-time data quality assessment. Software: The system must include and be compatible with: Windows 11 compliant Data Collection Software. GeneMapper ID-X Software v1.7 or higher for the analysis of human identification data. Features to support security, audit trails, and electronic signatures (SAE) to meet ISO 17025 and 21 CFR Part 11 requirements. Compatibility: Must provide data consistency with results from legacy Applied Biosystems 3130xl and 3500xl systems. Must be validated for use with Similiar forensic STR kits (e.g., GlobalFiler�, Yfiler� Plus, MiniFiler�) and BigDye� Terminator v1.1 Cycle Sequencing chemistry. Standards Compliance: The system must meet all ANSI National Accreditation Board (ANAB) to AR3125, ISO-17025 and Federal Bureau of Investigations (FBI) Quality Assurance Standards (QAS). The instrument must be developmentally validated by the manufacturer. Consumable Tracking: System must utilize Radio Frequency Identification (RFID) technology to track key consumables, lot numbers, and usage data. Application Flexibility: Must allow for both fragment analysis and Sanger sequencing runs on the same instrument and plates. Extended warranty and service contract. Shipping, Delivery, and Installation Shipping: The awardee shall handle all shipping, handling, and insurance for the ground shipment of the SeqStudio 24 Flex system and all accessories to AFMES. Freight terms are FOB Destination. Delivery Crew: The awardee will provide an appropriately staffed delivery crew to deliver the workstation to the designated room within the AFMES facility. Installation: The crew will unpack the instrument, place it on the identified workbench, and remove all debris associated with the movement and unpacking of the instrument. System Setup: A certified Field Service Engineer will install the SeqStudio 24 Flex Genetic Analyzer in accordance with the purchased installation services (P/N: A57822) and perform all necessary Installation Qualification (IQ) and Operational Qualification (OQ) procedures to ensure the system is functioning per manufacturer specifications. Computer and Software The vendor will provide an integrated touchscreen computer. The vendor will install and configure the GeneMapper ID-X v1.7 software on a separate Windows 11 computer workstation. Training The awardee shall provide on-site training for laboratory operators, delivered by a certified Field Application Specialist (FAS), as specified under P/N: A57823. Warranty The awardee shall provide a one-year manufacturer's warranty covering all parts, labor, and travel, effective from the date of installation acceptance. This Special Notice of is not a request for competitive quotes. Information received in response to this notice will be considered solely for the purpose of determining whether a competitive procurement is in the best interest of the Government. All questions and responses concerning this notice shall be submitted by e-mail to roberto.a.gonzalez-echeverria.civ@health.mil Interested concerns must identify their capability in writing to the above email address no later than 9:00 AM EST, 7 August 2026.

Who won similar work

7 award notices on SAM.gov in the last 24 months. Matched by: Same office (DEFENSE HEALTH AGENCY), same NAICS 334516.

Single-winner award sizes (7): middle half $66K to $557K, median $349K; range $40K to $5.9M.

WinnerAwardsValueLast
HOLOGIC SALES AND SERVICE, LLC1$5.9MJul 14, 2025
BIOMERIEUX INC1$627KSep 29, 2026
BECKMAN COULTER, INC1$486KAug 20, 2025
HAMILTON COMPANY1$349KJul 29, 2026
MEDTEC BIOLAB, INC.1$83KJul 16, 2026
TSI INCORPORATED1$50KSep 2, 2026
LUMINEX CORP1$40KJul 29, 2026

Value counts single-winner awards. "Shared" awards are multiple-award contracts that list every winner with the same total ceiling; that ceiling is not one company's win, so it is not added in. Revenue next to a ticker is the company's last annual revenue from its 10-K.

Latest awards

Competitive landscape

For the 7 most frequent past winners above. Lobbying is matched by the company's exact name or exact ticker; agencies are as named on the filings.

  • 0 of these past winners lobbied Defense, Dept of (DOD) or Office of the Secretary of Defense or Joint Chiefs of Staff since 2024 (0 filings)
  • 0 of their lobbyists list a past Defense, Dept of (DOD) or Office of the Secretary of Defense or Joint Chiefs of Staff job
  • No corporate PAC money from them to the overseeing committees since 2024
  • 0 foreign-agent (FARA) registrations
See who and the source records with Pro

Policy around it

Bills the past winners named while lobbying this agency's issues, rules from the department, and executive orders that name the agency, last 12 months.

  • 0 bills named on the past winners' lobbying filings
  • 32 rules from the department in the last 12 months
  • 0 executive orders naming the agency in the last 12 months
See who and the source records with Pro

Market

For past winners matched exactly to a listed company. Insider trades are open-market buys and sells (Form 4) in the last 90 days, shown as facts; our own study found insiders do not reliably buy ahead of awards. A sale marked 10b5-1 was made under a trading plan set up in advance.

  • 0 of the past winners are listed companies
  • 0 insider buys and 0 insider sells at them in the last 90 days
See who and the source records with Pro

Sources: SAM.gov notices and award notices; Senate LDA lobbying filings; FEC filings; FARA; Federal Register; congress.gov; SEC Form 4. Every row above links to its record.

Companies are matched to tickers by exact name only. A company we could not match shows no market rows; that is a miss, not a finding.